We are live on ! Find out more
CLOER

Clover Leaf Capital Corp. Rights
CLOER

Delisted

CLOER was delisted on the 3rd of September, 2024.

23 hedge funds and large institutions have $1.21M invested in Clover Leaf Capital Corp. Rights in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more funds holding

Funds holding: 2023 (+3)

56% less capital invested

Capital invested by funds: $2.74M → $1.21M (-$1.54M)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
23
Holders Change
+3
Holders Change %
+15%
% of All Funds
0.39%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
3
Closed
Calls
Puts
Net Calls
Net Calls Change

CLOER Hedge Fund Activity: Q2 2022 in Review

23 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Clover Leaf Capital Corp. Rights (CLOER) for Q2 2022, worth a combined $1.21M — down 56% from $2.74M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CLOER positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 3 trimmed.

The largest buyer was MMCAP International, opening a new position worth an estimated $156K. The largest seller was CVI Holdings, cutting an estimated $857.

  • 23 institutional investors held Clover Leaf Capital Corp. Rights (CLOER) as of Q2 2022, up from 20 in Q1 2022.
  • Funds reported $1.21M of Clover Leaf Capital Corp. Rights stock for Q2 2022, down 56% quarter-over-quarter.
  • 3 funds opened new Clover Leaf Capital Corp. Rights positions in Q2 2022 and 0 closed out, a net change of +3 holders.
  • The largest Clover Leaf Capital Corp. Rights buyer in Q2 2022 was MMCAP International, an estimated $156K added.
  • The largest Clover Leaf Capital Corp. Rights seller in Q2 2022 was CVI Holdings, an estimated $857 sold.

Based on aggregated 13F filings for Q2 2022.